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Abstract: The relationship between osteoporosis and lactose intolerance is unclear. This study
aims to evaluate the association between self-reported lactose intolerance and symptom severity
caused by lactose malabsorption and bone mineral density (BMD). A total of 496 American hip
arthroplasty patients took part in this study. Information on BMD and socio-demographic factors
were retrospectively extracted from medical records. BMD of the lumbar spine (LS), femoral neck
of the operative hip (FNOH), and femoral neck of the non-operative hip (FNH) were measured via
dual-energy X-ray absorptiometry scans (DXA). Patients also completed a survey regarding dietary
and lifestyle habits from the time of surgery. We found that 9.3% of participants reported lactose
intolerance and 33.3%% suffered from either osteopenia or osteoporosis in at least one (location).
The population that did not self-identify as lactose intolerant consumed significantly more dairy
(p < 0.0001) and animal protein (p = 0.004) than those with intolerance. There was no significant
difference in BMD between self-identified lactose intolerant individuals and non-lactose intolerant
individuals. In a stepwise multiple regression analysis, body mass index (BMI) and age were the only
common predictors of BMD for all locations (p < 0.05). However, yogurt intake was a significant
predictor of BMD of FNOH in the multivariate analysis. This study suggests that lactose intolerance is
not associated with bone mineral density. We also found that being vegan or vegetarian may increase
the risk of low BMD.
Keywords: lactose intolerance; osteoporosis; bone mineral density; dairy intake
1. Introduction
Osteoporosis is a skeletal disorder defined by bone mass degradation [1], creating irreversible
changes in bone structure and increasing fracture vulnerability [2]. Osteoporosis is a silent disease [3]
that does not elicit symptoms before a fracture occurs [1]. Worldwide, nearly 200 million people
are affected by low bone mass, attributing to 8.9 million fractures each year [3]. By the year 2050,
fracture rates are expected to increase by 240% in women and 310% in men [4]. Consequently,
5964 disability-adjusted life years (DALYs) were lost in North America and Europe due to hip
fractures [5], attributable to 0.21% of the total global burden of disease [6]. The financial and social
burden posed by this condition impels a clear understanding of the risk factors involved in its
development so that preventative measures may be implemented.
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Dual-energy x-ray absorptiometry (DXA) scans are the most widely validated means for measuring
bone mineral density (BMD) [7]. As BMD declines, the risk of fragility fractures increases incrementally.
Thus, parameters for osteoporosis and osteopenia (low bone mass, but to a lesser extent than
osteoporosis) are typically based on BMD [8].
Calcium consumption has been promoted to prevent and treat osteoporosis [9]. In the USA,
nearly three-quarters of dietary calcium is derived from dairy [10]. However, on a global scale,
calcium consumption and hip fracture rates appear to be inversely related [11,12]. While developing
nations consume less dairy [13], they also experience fewer hip fractures [12,14]. Communities
consuming more calcium suffer from more osteoporosis [15]. African Bantu women, for instance,
consume on average one-third of the USA recommended dietary allowance of calcium for adults
(1000 mg/day) [16], without dairy or calcium supplementation, and exhibit the lowest incidence of
osteoporosis in the world. However, differences in sunshine exposure, physical activity, and other
aspects of lifestyle exist between Western and African populations, particularly in rural areas.
While genetics may account for over 50% of bone density [17], the remainder is dependent
on environmental factors such as exercise, hormonal status, and/or dietary factors [18] including
protein, fibre, iron, alcohol, sodium, potassium, phosphorous, magnesium, fluoride, and vitamins
A, B, C, and K [18]. Thus, the paradoxical relationship between high calcium intake and heightened
osteoporosis prevalence is likely the result of many intertwined factors.
Vitamin D, produced via skin exposure to sunlight, is essential for calcium absorption. Variations
in vitamin D availability could potentially confound migration studies and/or other analyses of diet
and fracture rate. Long-term, excessive calcium consumption may also impair calcium and vitamin D
regulatory systems [12]. This risk might be especially dangerous for populations consuming high levels
of animal protein [11,12,19,20]. As animal protein is digested, it stimulates acid release from the stomach.
To buffer the corresponding metabolic acid load, this, in turn, enhances calcium excretion. Whether the
amount of calcium retained in the body overrides the amount excreted is controversial. Some research
has documented a net calcium loss alongside animal protein consumption [21], while other studies
have indicated that, regardless of urinary excretion, bodily stores of calcium may not be affected [22]
or may even improve [23].
Intake of plant protein does not seem to increase urinary calcium excretion [20]. Globally,
the greater the ratio of animal protein to plant protein consumption, the greater the incidence of
fractures [19]. Furthermore, calcium absorption rates are affected by the combination of all available
nutrients (e.g., animal protein, sodium, potassium levels, etc.). Therefore, analyzing calcium content
alone (of specific food or a diet) is insufficient to determine bioavailability. Recommended daily
allowance of calcium may vary greatly depending on the specific calcium source and overall diet
composition. For instance, while sodium consumption enhances urinary calcium excretion, increasing
dietary potassium may counteract this, particularly in postmenopausal women [24].
As dairy is a rich source of calcium, animal protein, and often sodium, its effects on osteoporosis
are unclear. Lactose intolerant individuals (LIIs) in the USA, who typically avoid dairy, but otherwise
follow a western diet [25], may help clarify this trend. LIIs lack the enzyme lactase, responsible for
break lactose into two monosaccharides, glucose and galactose, before being absorbed across the
intestinal mucosa [26]. Without lactase, lactose is passed into the large intestine, where it is digested
via bacterial fermentation causing abdominal cramps, flatulence, vomiting, diarrhoea, and/or audible
bowel sounds [27].
Most people are lactase secretors at birth, but lose this ability at some point during maturation.
Persistence of lactase secretion throughout adulthood varies greatly [11], creating a variable degree
of lactose intolerance throughout the world [28]. The prevalence of LIIs in the USA varies greatly
according to ethnic groups: 10–15% of Caucasians, 65–75% of African Americans [29], 60% of Hispanics,
and 100% of Asian-Americans and Native Americans [10]. However, the available literature is unclear
regarding the effects of lactose intolerance on bone health [25]. While some studies have demonstrated
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positive relationships between lactose intolerance, osteoporosis [10], and low BMD [30,31], other studies
have found no significant associations between lactose intolerance and BMD [10,25,32].
This study aimed to add to the existing body of literature regarding bone health and lactose
intolerance by assessing whether lactose intolerance is associated with low BMD due to lower dairy
consumption, and whether the severity of symptoms, caused by lactose maldigestion, affects BMD
among LIIs.
2. Materials and Methods
2.1. Study Design and Population
This was a cross-sectional study of adult patients who underwent hip arthroplasty at a private
surgery centre in the United States (Columbia, South Carolina) between 2003 and 2017, with available
demographic data and DXA scans in a computerised medical records database and retrospectively
completed a questionnaire on symptoms of lactose intolerance, dietary intake, and lifestyle factors at
the time of the surgery.
Participants were selected via convenience sampling, based on the availability of BMD scores
at a surgery center in the United States. All patients received hip arthroplasty surgery (either total
hip replacement or hip resurfacing). Hip resurfacing is typically performed on younger patients
with severe degenerative hip arthritis/osteoarthritis (approximately 70%), but also hip dysplasia,
osteonecrosis, and post traumatic arthritis [33]. The BMD of osteoarthritic patients may be greater than
the general population [34]. Patients aged <18 years or with missing or inaccurate contact information,
missing BMD t-scores, and/or death were excluded. Patients who received bilateral hip arthroplasty
were only analyzed in respect to their first operation.
In total, 3781 adult patients (71% male, 29% female) were identified and 2770 were deemed eligible
to participate in the study (Figure 1). A survey, a study information sheet, and informed consent were
sent to all eligible patients. When email addresses were available, participants received electronic
questionnaires (n = 1370, 49.46%). All other participants were contacted by mail (n = 1400, 50.54%).
Out of 2770 invited to participate in the study, 496 completed the survey and informed consent.
Figure 1. Flow chart of participants’ recruitment.
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A sample size of 496 participants yielded a power of 0.978, deducing that sample size was adequate
and the likelihood of a type two error was small. The power analysis was performed in G*Power
software for Macintosh OS/OS X (version 3.1.9.2; Heinrich-Heine-University, Düsseldorf, Germany).
2.2. Data Collection
The survey inquired about dietary habits, exercise, menopausal status, medications, vitamin
supplementation, and lactose intolerance at the time of hip arthroplasty surgery. Calcium
supplementation, use of digestive aids, cardiovascular exercise, and strength-building exercise were
recorded in intervals (<1 time weekly, 1–3 times weekly, 4–7 times weekly, and >7 times weekly).
The survey included broad questions on intake of milk, cheese, yogurt, egg, meat/poultry/fish,
calcium-fortified products, and lactose-free milk consumption. The frequency was recorded at similar
intervals (<1 time weekly, 1–3 times weekly, 4–7 times weekly, and >7 times weekly). Dairy consumption
was estimated as a sum of all dairy (milk/butter, cheese, and yogurt) intake, ranging from 3 to 12.
For example, a score of 3 represented <1 weekly serving of each dairy product, and a score of 12
represented >7 weekly servings of each dairy product. Animal protein consumption was estimated
as a sum of meat/poultry/fish, egg, and dairy intake, ranging from 5 to 20. For example, a score of
5 represented <1 weekly serving of each animal product, and a score of 20 represented >7 weekly
servings of each animal product.
Participants were asked whether they had been diagnosed with lactose intolerance by a physician.
Lactose intolerance was self-reported and not confirmed by hydrogen breath tests or prove of physician
diagnosis. The severity of lactose intolerance was measured on a visual analogue scale, measuring 5
items: flatulence, diarrhoea, vomiting, abdominal cramping, and audible bowel sounds. The scale
ranged from no symptoms (0) to maximum symptoms (10), based on a validated lactose intolerance
questionnaire [27]. The length of lactose intolerance and calcium supplementation were recorded in
intervals (<1 year, ≥1 but <5 years, and ≥5 years). Multiple choice and open-ended questions inquired
about the active pursuit of dietary calcium.
The medical records database was established preoperatively. BMD of the femoral neck of the
operative hip (FNOH), the femoral neck of the non-operative hip (FNH), and/or lumbar spine (LS)
were measured by DXA scans. T-scores were used as a point of comparison amongst participants [35],
following WHO guidelines for osteoporosis (t-scores ≤−2.5) and osteopenia (t-scores between −1 and
−2.5) [36].
Preoperative weight and height were extracted from the medical database and used to calculate
body mass index (BMI, kg/m2). Patients were classified as underweight (<18.5), normal-weight
(≥18.5 and <25), and overweight (≥25 and <30) and obesity (≥30) according to the WHO (2017) BMI
cutoff points. Residential latitude, based on patients’ zipcode, was determined by the [37]. Participants
who live at/above 37◦C or at/below −37◦C latitude were referred to as at-risk latitude (ARL), denoting
the decreased availability of vitamin D at such localities [38]. All patients who lived within −37 and
37 degrees latitude were referred to as no risk latitude. Latitude was used in this study as a proxy of
sun exposure at the time of the surgery.
2.3. Ethics
The study followed ethical guidelines established by the Health Insurance Portability and
Accountability Act of 1996 and The Data Protection Act of 1998. The project was approved by ethics
committees at both Providence Hospital (United States) and the University of Westminster (UK
reference code ETH1617-0769). All patients were provided with a patient information sheet and
signed a letter of consent. Patient information sheets included a phone number and email address for
questions and/or clarification, as needed.
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2.4. Statistical Analysis
The general characteristics of the study population were reported as mean ± SE for continuous
variables and absolute (n) and relative frequency (%) for categorical variables. Lactose intolerance
was analyzed as a binary variable (yes/no). The severity of lactose intolerance was measured as a
continuous variable, with the sum of all symptoms ranging from 0 to 50 [27]. Poor bone health (PBH)
was defined as T-scores < −1.0 (inclusive of osteoporosis and osteopenia). The Shapiro–Wilk test was
used to test for normality.
Pearson’s chi-square test and unpaired t-test were employed to detect differences in
socio-demographic factors, BMI, BMD, dietary intake, use of dietary supplements, and menopausal
status (only for women) between lactose intolerant and non-lactose intolerant participants. One way
ANOVA was performed to test differences in BMD of the FNOH, FNH, and LS according to the general
characteristics of the study population. A significance level of alpha <0.05 was used for comparison
between groups. Turkey’s multi-comparison test was employed as a post-hoc analysis.
To avoid loss of information associated with categorization, dependent variables (BMD of the
FNOH, FNH, and LS) were analyzed as continuous. Multiple linear regression was performed to
identify predictors of BMD. All available covariates that could influence BMD, according to current
literature, were explored, including calcium supplementation, lactose intolerance, gender, BMI, the
sum of all dairy and protein consumption, and latitude. Variables were included in the model when
they were correlated with the dependent variables (BMD of the FNOH, FNH, and LS) in the bivariate
analysis (p < 0.20). With these variables, a stepwise multiple linear regression analysis was performed.
Associations were considered significant in the final model when the p-value was <0.05. Within the
lactose intolerant population, the severity of symptoms was analysed with a linear regression model.
A significance level of alpha <0.05 was used to measure the strength of this relationship. SPSS®
(version 24; IMB corp., Chicago, IL, USA) was used for all statistical analyses.
3. Results
Table 1 shows the general characteristics of the study population of 496 patients who had hip
arthroplasty according to lactose intolerance status. In total, 68.9% (342) of the study population were
male, 9.3% (46) reported lactose intolerance and 33.3% (165) had either osteopenia or osteoporosis in at
least one location (Table 1).
Of the lactose intolerant population, only 6.5% (3) reported a physician diagnosis of lactose
intolerance; 65.2% (30) were males, 13% (6) reported taking vitamin D supplements, and 24.3%
(9) reported taking calcium supplements (Table 1). Individuals with lactose intolerance did not
significantly differ from those without lactose intolerance regarding most of the variables assessed
with the exception of vitamin D supplementation, consumption of food fortified with calcium, dairy,
and protein. Individuals without lactose intolerance were more likely to take vitamin D supplements
and consume food fortified with calcium at least once a week and report a higher intake (sum of
frequency score) of dairy consumption and animal protein.
Table 2 shows the mean bone mineral density (BMD) (t-score) for femoral neck of the operative hip
(FNOH), femoral neck of the non-operative hip (FNH), and lumbar spine (LS) according to population
characteristics. There was a trend toward lower BMD among women compared to men. However,
the results were only significant for the lumbar spine. Postmenopausal women have significantly
lower BMD than pre and perimenopausal women in all three BMD indicators (FNOH, FNH, and LS).
Mean BMD did not differ according to the consumption of calcium supplement, foods fortified with
calcium, milk, cheese, reporting cardiovascular exercise, and living in at-risk latitude.
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Table 1. Characteristics of patients who received hip arthroplasty between 2003 and 2017; Columbia,
South Carolina, United States of America.




n = 450 p-Value
Gender
Male 342 (68.9%) 30 (65.2%) 312 (69.3%) 0.566 b
Female 154 (21.1%) 16 (34.8%) 138 (30.7%)
At-risk latitude
Yes 145 (29.2%) 13 (28.3%) 132 (29.3%) 0.879 b
No 351 (70.8%) 33 (71.7%) 318 (70.7%)
Smoking Status
Smokers 7 (1.4%) 0 (0.0%) 7 (1.6%) 0.386 c
Non-smokers 489 (98.6%) 46 (100.0%) 443 (98.4%)
BMI categories d 0.773 c
Underweight 7 (1.5%) 0 (0.0%) 7 (1.7%)
Healthy weight 173 (37.5%) 19 (45.2%) 154 (36.7%)
Overweight 186 (40.3%) 15 (35.7%) 171 (40.8%)
Obese 95 (20.6%) 8 (19.1%) 87 (20.8%)
Menopausal status of women e 0.672 b
Pre or perimenopausal 59 (38.3%) 9 (56.2%) 50 (36.2%)
Postmenopausal 95 (61.7%) 7 (43.7%) 88 (63.8%)
Vitamin D Supplementation 0.015 b
Yes 117 (23.6%) 6 (13.0%) 111 (24.7%)
No 379 (76.4%) 40 (67.0%) 339 (75.3%)
Calcium supplementation 0.484 b
Yes 142 (29.0%) 9 (24.3%) 133 (43.0%)
No 354 (71.0%) 37 (75.7%) 317 (57%)




Yes 437 (88.1%) 20 (43.5%) 417 (92.7%)
No 59 (11.9%) 26 (56.5%) 33 (7.3%)
Vegan or vegetarian 0.147 c
Yes 480 (97%) 3 (6.5%) 12 (2.7%)
No 15 (3.0%) 43 (93.5%) 437 (97.3%)
Cardiovascular exercise at least once
a week for 30 min 0.372
b
Yes 382 (77.0%) 33 (71.7%) 349 (77.7%)
No 114 (23%) 13 (28.3%) 101 (22.4%)
Surgery Type 0.724 b
Hip resurfacing surgery 481 (97.0%) 45 (97.8%) 436 (96.9%)
Total hip replacement surgery 15 (3.0%) 1 (2.2%) 14 (3.1%)
Osteoporosis or osteopenia 0.123 b
Yes 165 (33.3%) 20 (43.5%) 145 (32.2%)
No 331 (66.7%) 26 (56.5%) 305 (67.8%)
Continuous Variables f p-Value g
Age (years) 60.0 (0.40) 58.7 (2.27) 60.20 (0.38) 0.295
Sum of all dairy consumption 6.82 (0.81) 5.65 (0.28) 6.94 (0.08) <0.0001
Sum of all protein consumption 12.01 (0.11) 11.04 (0.34) 12.11 (0.11) 0.004
BMI (kg/m2) 26.23 (0.21) 25.57 (0.63) 26.29 (0.23) 0.295
(a) categorical data reported as n (%), (b) p-value for Chi-Square test, (c) p-value for Fisher exact-test, (d) analysis
was performed among 461 subjects with valid BMI measurement, (e) analysis was performed among women only
(n = 154), (f) continuous data reported as mean and SE, (g) p-value for an unpaired t-test, BMD—bone mineral
density, BMI—body mass index.
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Table 2. Differences in bone mineral density (BMD) t-scores according to different independent variables.
Variables BMD: Femoral Neck of theOperative Hip
BMD: Femoral Neck of the
Non-Operative Hip BMD: Lumbar Spine
All Study Participants
(n = 496) Mean (SE) p-Value Mean (SE) p-Value Mean (SE) p-Value
Gender 0.062 0.076 0.017
Males −0.16 (0.07) −0.10 (0.06) 1.31 (0.11)
Females −0.42 (0.11) −0.30 (0.10) 0.84 (0.15)
Calcium supplementation 0.202 0.707 0.325
Yes −0.36 (1.00) −0.13 (0.87) 1.04 (1.76)
No −0.18 (0.80) −0.17 (0.64) 1.24 (1.07)
Vitamin D supplementation 0.005 0.085 0.613
Yes −0.27 (1.00) −0.12 (1.06) 0.97 (1.91)
No −0.85 (1.19) −0.55 (1.12) 0.57 (1.93)
Consumption of food fortified
with calcium >1 time/week 0.070 0.181 0.973
Yes −0.19 (0.07) −0.14 (0.05) 1.17 (0.10)
No −0.56 (0.18) −0.35 (0.15) 1.16 (0.26)
Consumption of milk >1
time/week 0.942 0.486 0.624
Yes −0.23 (0.07) −0.18 (0.05) 1.19 (0.10)
No −0.25 (0.14) −0.07 (0.14) 1.06 (0.25)
Consumption of cheese >1
time/week 0.434 0.700 0.274
Yes −0.22 (0.07) −0.16 (0.05) 1.13 (0.09)
No −0.38 (0.20) −0.22 (0.15) 1.44 (0.33)
Consumption of yogurt >1
time/week 0.015 0.269 0.853
Yes −0.11 (0.08) −0.12 (0.70) 1.16 (0.12)
No −0.42 (0.93) −0.23 (0.07) 1.19 (0.14)
Vegan or vegetarian 0.049 0.068 <0.001
Yes −1.0 (0.41) −0.69 (0.23) −0.75 (0.52)
No −0.21 (0.06) −0.15 (0.05) 1.22 (0.9)
At-risk Latitude 0.103 0.652 0.643
Yes −0.05 (0.11) −0.13 (0.10) 1.10 (1.63)
No −0.29 (0.08) −0.18 (0.61) 1.19 (1.07)
Menopausal status of women
only a 0.0036 <0.001 0.005
Pre or perimenopausal −0.15 (0.07) −0.07 (0.06) 1.30 (1.65)
Postmenopausal −0.61 (0.13) −0.55 (0.100) 1.540 (1.58)
BMI (kg/m2) <0.0001 <0.0001 <0.001
Underweight −1.4 (0.98) −1.30 (1.34) −1.14 (1.35)
Healthy −0.54 (1.16) −0.46 (1.07) 0.85 (1.75)
Overweight −0.16 (1.16) −0.11 (1.11) 1.23 (1.79
Obese 0.28 (1.08) 0.29 (1.09) 1.624 (1.56)
Cardiovascular exercise at
least once a week for 30 min 0.546 0.133 0.753
Yes −0.21 (0.07) −0.12 (0.06) 1.15 (0.10)
No −0.30 (0.14) −0.31 (0.11) 1.22 (0.17)
(a) analysis was performed among women only (n = 154); BMD—bone mineral density, BMI—body mass index.
Individuals who reported consumption of vitamin D supplements tended to have higher BMD
means. However, the results were significant (p < 0.05) for FNOH only. Individuals who reported
consumption of yogurt more than once a week presented significantly higher BMD FNOH compared
to those who did not consume yogurt or consume less than once a week (p = 0.015). Results for FNH
and LS were not statistically significant.
Lower BMD for femoral neck of the operative hip, femoral neck of the non-operative hip, and
lumbar spine among vegetarian and vegan individuals was observed compared to those who reported
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consumption of animal foods. The results reached statistical significance for LS (p <0.001) and FNOH
(0.049) and presented borderline p-values (p = 0.068) for FNH. Mean BMD significantly varied across
BMI groups in all three indicators (FNOH, FNH, LS). The higher the BMI category the higher the mean
BMD (Table 2).
3.1. Analysis of the Lactose Intolerant Population
The average length of lactose intolerance was 2.43 ± 0.82 years. The average severity of symptoms,
when consuming lactose, was 18.31 ± 10.89. As presented in Table 3, the average BMD did not
significantly differ between those with or without lactose intolerance. In the bivariate analysis among
those who have lactose intolerance (n = 461), there was a trend towards a positive relationship between
the severity of lactose intolerance symptoms and BMD, but the results were not statistically significant
for FNOH and FNH. BMD of LS was the only indicator that reached statistical significance in the
linear bivariate analysis between the score of severity of symptoms and BM (Coefficient = 0.06, SE 0.02,
p = 0.047). When this model was adjusted for intake calcium supplement, the association was no
longer significant (results not shown).












BMD: Femoral neck of the
operative hip −0.23 (0.63) −0.30 (0.22) −0.23 (0.65) 0.766
BMD: Femoral neck of the
non-operative hip −0.16 (0.05) −0.23 (0.17) −0.16 (0.05) 0.698
BMD: Lumbar spine 1.17 (0.09) 1.19 (0.33) 1.17 (0.09) 0.954
BMD—bone mineral density.
3.2. Predictors of Bone Mineral Density
In a stepwise multiple linear regression (Table 4), BMI and age were the common predictors of
BMD for all three indicators. BMI was positively associated with BMD while age was negatively
associated with BMD. Consumption of yogurt was positively associate with BMD FNOH, while
cardiovascular exercise was positively associated with BMD FNH. For LS, gender and being vegan or
vegetarian were also significant predictors.
Table 4. Predictors of Bone Mineral Density according to a stepwise linear regression model.
Variables BMD: Femoral Neck of the Operative Hip BMD: Femoral Neck of the Non-Operative Hip BMD: Lumbar Spine
β (SE) p-Value β (SE) p-Value β (SE) p-Value
BMI (kg/m2) 0.06 (0.01) <0.0001 0.07 (0.11) <0.0001 0.06 (0.02) 0.008
Age (years) −0.16 (.01) 0.047 −0.02 (.01) 0.001 −0.03 (0.01) 0.004
Yogurt >1 time/week 0.33 (0.13) 0.014
Cardiovascular exercise
>1 time/week 0.35 (0.12) 0.005
Gender (males) 0.43 (0.21) 0.04
Vegan or Vegetarian −1.26 (0.59) 0.33
Adjusted R2 7.4% 10.3% 7.3%
BMD—bone mass density.
4. Discussion
This study aimed to analyse the difference in BMD according to lactose intolerance status while
accounting for various dietary and lifestyle factors and to determine whether the severity of lactose
intolerance symptoms affects BMD. The results demonstrated that BMD did not differ significantly
between lactose intolerant and lactose tolerant individuals, albeit greater consumption of animal protein
and dairy by lactose tolerant individuals. The results also showed that being vegan or vegetarian is
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associated with lower BMD of the lumbar spine. These results concur with several previous studies.
In a study of 34 lactose intolerant individuals (LIIs), Alhava et al. [39] found that participants consumed
significantly less milk and dietary calcium than the normal population, however, the osteoporotic
risk did not differ from previously established normal values. In another study of 218 individuals,
Kudlacek et al. [25] found no significant difference in BMD between LIIs (n = 115) and non-LIIs
(n = 103). However, this study established lactose intolerance based on physician diagnosis alone (via
a hydrogen breath test) and not all LIIs demonstrated clinical symptoms of intolerance. It is, therefore,
possible that calcium consumption did not differ between groups.
In a study of 58 post-menopausal Italian women, Corazza et al. [30] also found that lactose
intolerance did not directly influence BMD and that calcium intake and symptom severity were
inversely related. This would suggest that the more severely individuals experienced symptoms
of intolerance, the less dairy he/she consumed. Similarly, in the Kudlacek et al. [25] study on BMD
and self-reported symptoms of lactose intolerance, no significant differences were found between
BMD of the lumbar vertebrae and nondominant distal radius. However, of the 115 lactose intolerant
individuals, 17% reported no symptoms of intolerance. Kudlacek et al. [25] deduced that individual
perception of symptomology may be a better predictor of BMD than clinical diagnosis, as patients with
severe intolerance are expected to avoid dairy. In the current investigation, we found that within the
lactose intolerant population, those who experienced the most severe symptoms of lactose intolerance
demonstrated stronger BMD of the lumbar spine. No relationship was apparent in the FNH or FNOH.
The Austrian study [25] previously reported no significant difference in BMD between the lactose
intolerant individuals and non-LIIs. Furthermore, Slemenda et al. [40] also employed hydrogen breath
tests to analyse lactose intolerance. In a sample of 342 adult, female twins, data showed no significant
correlation between lactose intolerance and BMD of the femoral neck or midshaft radius. However,
physician-diagnosed lactose intolerance does not always manifest with symptoms [25,41]. In both
studies, hydrogen breath test diagnoses were used for some individuals who were unaware of their
status. Therefore, the participants may have consumed dairy without any symptoms of intolerance
and could have consumed unlimited dairy products. By analysing self-reported lactose intolerance,
versus hydrogen breath test diagnoses, the current investigation may have a heightened sensitivity to
self-imposed dairy restrictions.
In the stepwise multiple regression analysis, the amount of dairy consumption was not a significant
predictor of BMD. We only found a significant association between yogurt intake and BMD of FNOH.
The inaccuracy of retrospective food frequency questionnaires may have underestimated this association.
Lactose intolerance symptoms may, therefore, be a more accurate depiction of dairy avoidance.
As the current investigation was based on self-reported lactose intolerance, all lactose intolerant
individuals experienced symptoms of maldigestion. Thus, findings that the non-lactose intolerant
population consumed significantly more dairy than the lactose intolerant population are logical.
Many studies conclude that by reducing dairy intake, calcium intake simultaneously decreases [9],
placing lactose intolerant individuals at heightened risk of osteoporosis [42]. Although there was
significantly less dairy consumption by lactose-intolerant individuals, no significant difference in BMD
was observed in this study between lactose intolerant individuals and non-LIIs.
Additionally, the majority of research that correlates lactose intolerance to low BMD attributes
this relationship to a reduction of dietary calcium intake [31,32]. Other studies also describe this
relationship to the absence of lactose [43], since lactose increases calcium diffusion and may osmotically
alter junctions between epithelial cells [44]. However, these reports require further investigation [31,45].
According to Weaver et al. [9], adequate levels of calcium may be attained from plant-based
sources, though it is less concentrated and therefore more practical to consume dairy. However, it is
well documented that food is more than the sum of its parts [46]. Nutrients, such as calcium, cannot
be analysed in isolation, as compounds often behave differently depending on the synergistic or
pernicious effects of the composite [46].
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In addition to high levels of dietary calcium, dairy products are often high in animal protein
and sodium, both of which enhance urinary calcium excretion. This may explain why calcium is
more readily absorbed from green vegetables and legumes (40–64%) than from dairy (32%) [47].
Therefore, rather than recommending dairy to support bone health, plant-sourced calcium may be
superior [48–52]. Different dietary patterns (e.g., plant-based vs. meat-rich diets) may also necessitate
different thresholds of calcium, potentially explaining why nations consuming the most animal protein
suffer from the greatest incidence of fractures [19,20]. However, in the present study, we found that
being vegan or vegetarian was negatively associate with BMS of the lumbar spine. However, this study
lacks comprehensive habitual dietary data, detailed information of dietary supplementation, and blood
levels of calcium and vitamin D to clarify if this association was mediated by factors related to the
quality of the diet and specific macro and micronutrients.
The findings from this study demonstrated that non-LIIs consumed significantly more animal
protein than lactose intolerant individuals. However, neither group differed in egg, fish, poultry, or
meat consumption, indicating that lactose-intolerant individuals did not significantly substitute animal
products for dairy. It is, therefore, possible that lactose-intolerant individuals either require less dietary
calcium than the non-LIIs, used more of lactose or milk derived non dairy products such as breakfast
cereal [53], or that plant-based alternatives provided enough supply of calcium [47].
No significant association between calcium supplementation and BMD was found in this study,
this is consistent with a previous systematic review which found that calcium intake is not significantly
associated with hip fracture risk in women or men [54]. A longitudinal study of 955 post-menopausal
women in London used DXA scans to measure BMD and found that calcium supplementation had no
effect on bone health [55]. This may be due to the lack of vital nutrients in calcium supplements, such
as thiamine, riboflavin, B-6, and B-12, that are often found in calcium-rich foods [9]. As previously
mentioned, nutrients are synergistic and may absorb differently when consumed in isolation. Increasing
research has also demonstrated potentially harmful side effects of calcium supplements, including
gastrointestinal distress and cardiovascular disease [54,56].
It is important to note that research in favour of calcium supplementation often incorporates
vitamin D supplementation into treatment [57–59]. Unlike calcium supplements, vitamin D has not been
linked to harmful side effects (given that daily consumption does not exceed 10,000 IU). Consumption
of vitamin D supplements is widely advocated especially in populations living above 37 degrees or
below −37 degrees latitude [38]. A double-blind, placebo-controlled trial of postmenopausal women
in Scotland found that supplements of 400 IU a day are essential to improve bone health [60]. Similarly,
the current investigation found vitamin D supplements to have a positive effect on BMD of the FNH.
However, vitamin D supplementation did not remain a significant predictor in the multivariate analysis.
Several potential predictors of BMD were included in a stepwise multiple linear regression
analysis. However, only BMI and age were found to be significant predictors of BMD of the FNOH,
FNH, and LS. In accordance with the literature [3], this study demonstrated a positive correlation
between BMI and BMD of FNOH, FNH, and LS. Additionally, BMD of the FNOH, FNH, and LS was
significantly lower for postmenopausal women. It is widely accepted that high BMI is protective
against osteoporosis [3]. The current investigation study supports this theory.
Strengths and Limitations
Several strengths and weaknesses result from the retrospective nature of this study. The response
rate among eligible participants was 18.5% (512 out of 2770), and 496 out of 512 participants had
completed survey data. Although a low response rate is common epidemiological studies, it can
limit the generasibility of our findings. Recall of diet and lifestyle from the time of surgery may be
inaccurate, as some surgeries occurred 14 years ago. Although the questionnaire captured intake of
supplements, we did not measure the actual blood levels of calcium and vitamin D. To account for these,
questionnaires were broad, capturing ranges versus precise numbers (e.g., calcium supplementation).
The residential latitude at the time of the surgery was used as a proxy of sun exposure. However,
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individuals living in low-risk latitude can still have limited sun exposure due to cultural factors
(clothing) and use of sun blocker. There are a number of factors involved in the development of
osteoporosis, such as glucocorticoid therapy and hyperparathyroidism, to mention a few. However,
these conditions were not considered as potential confounders in the association between lactose
intolerance and BMD. Furthermore, information about all potential predictors was not available,
including detailed information on ethnicity, education, and income. However, general information
about the clinic profile shows that the majority of patients were white caucasians with middle and high
socio-economic status. This might be due to the fact that the clinic was private. This study also relied
on self-reported lactose intolerance, versus physician diagnoses or the use of a hydrogen breath test.
Because symptoms of lactose intolerance were of primary interest, self-reported intolerance was likely
more apt at recognizing dairy avoidance and severity of intolerance. However, without a diagnosis,
it is possible that other medical conditions, such as irritable bowel syndrome, may have been mistaken
for lactose intolerance.
Medical record research was also employed, which relies on the consistency and accuracy of data
input [60]. However, patient medical records are still considered the gold standard in any study to
identify demographic factors, clinical data variables, specific aspects related to treatment regimes,
and ultimately patient mortality and morbidity [61].
Furthermore, the small sample size of lactose-intolerant individuals (n = 46) may lack statistical
power to detect significant differences between groups. Lactose intolerant individuals may also vary
greatly in their level of nutritional awareness, which may affect which food sources replace dairy items.
It is expected that lactose-intolerant individuals who actively seek calcium-rich plant foods should
have stronger BMDs than individuals who do not carefully plan their diet. For this reason, it is possible
that the results of this study are not applicable to all dairy abstaining populations.
5. Conclusions
This study found that individuals with lactose intolerance were not significantly different from
individuals without lactose intolerance in relation to most of the variables, although the latter group
was more likely to consume vitamin D supplements and higher intake of dairy and animal protein.
In addition, there was significant variation in the mean BMD in the different BMI groups in
all three indicators (FNOH, FNH, and LS) and the higher the BMI category, the higher the mean
BMD. While BMI was positively associated with BMD, age was negatively associated with BMD.
Furthermore, the mean BMD was not significantly different between those with or without lactose
intolerance. Further research involving prospective studies and more comprehensive food frequency
questionnaires are essential to confirm these findings and better understand how the consumption of
dairy products is linked to low BMD.
Author Contributions: Conceptualization, methodology, N.K.H. and A.R.A.A.; formal analysis, N.K.H. and
A.R.A.A.; writing—original draft preparation, O.O., N.K.H., and A.R.A.A.; writing—review and editing O.O.,
N.K.H., and A.R.A.A. All authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Acknowledgments: I would like to acknowledge Thomas Gross and Melissa (Dani) Gaillard Campbell of Midlands
Orthopaedics & Neurosurgery for their support throughout my research.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
DALY disability-adjusted life years
DXA dual-energy X-ray absorptiometry
BMD bone mineral density
SD standard deviations
WHO World Health Organization
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LIIs lactose intolerant individuals
FNOH femoral neck of the operative hip
FNH femoral neck of the non-operative hip
LS lumbar spine
BMI body mass index
ARL at risk latitude
NRL no risk latitude
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ANOVA one-way analysis of variance
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